BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 19080990)

  • 21. Infliximab treatment of psoriasis in supervised infusion centers: case management experience.
    Campos Muñoz L; de Unamuno Bustos B; Herranz Pinto P; El Ahmed HH; Ruiz-Villaverde R; Taberner Ferrer R
    Am J Clin Dermatol; 2014 Feb; 15 Suppl 1():S17-24. PubMed ID: 24777572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infliximab (Remicade) for acute, severe pustular and erythrodermic psoriasis.
    Lisby S; Gniadecki R
    Acta Derm Venereol; 2004; 84(3):247-8. PubMed ID: 15202853
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of pustular psoriasis with infliximab.
    Weishaupt C; Metze D; Luger TA; Ständer S
    J Dtsch Dermatol Ges; 2007 May; 5(5):397-9. PubMed ID: 17451384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infliximab for psoriasis.
    Gottlieb AB
    J Am Acad Dermatol; 2003 Aug; 49(2 Suppl):S112-7. PubMed ID: 12894134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of primary varicella infection during infliximab treatment for psoriasis.
    Balato N; Gaudiello F; Balato A; Ayala F
    J Am Acad Dermatol; 2009 Apr; 60(4):709-10. PubMed ID: 19293027
    [No Abstract]   [Full Text] [Related]  

  • 26. Addition of low-dose methotrexate to infliximab in the treatment of a patient with severe, recalcitrant pustular psoriasis.
    Barland C; Kerdel FA
    Arch Dermatol; 2003 Jul; 139(7):949-50. PubMed ID: 12873907
    [No Abstract]   [Full Text] [Related]  

  • 27. Autoimmunity by anti-tumour necrosis factor-alpha agents: the role of traditional therapies.
    Antoniou C; Moustou AE; Vergou T; Stratigos A; Kalambokas A; Katsambas AD
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):356-7. PubMed ID: 19686257
    [No Abstract]   [Full Text] [Related]  

  • 28. Systemic therapy for psoriasis.
    Lee M; Kalb RE
    Dermatol Nurs; 2008 Apr; 20(2):105-11; quiz 112. PubMed ID: 18549125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of recalcitrant palmoplantar pustular psoriasis with sequential use of infliximab and adalimumab.
    Yawalkar N; Hunger RE
    Dermatology; 2009; 218(1):79-83. PubMed ID: 18974629
    [No Abstract]   [Full Text] [Related]  

  • 30. Severe recalcitrant nail psoriasis responding dramatically to infliximab: report of two patients.
    Hussain W; Coulson I; Owen C
    Clin Exp Dermatol; 2008 Jul; 33(4):520-2. PubMed ID: 18462438
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term study of infliximab for psoriasis in daily practice: drug survival depends on combined treatment, obesity and infusion reactions.
    Spertino J; Lopez-Ferrer A; Vilarrasa E; Puig L
    J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1514-21. PubMed ID: 25493314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythrodermic, recalcitrant psoriasis: clinical resolution with infliximab.
    Rongioletti F; Borenstein M; Kirsner R; Kerdel F
    J Dermatolog Treat; 2003 Dec; 14(4):222-5. PubMed ID: 14660268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infliximab for the treatment of extensive plaque psoriasis--regulation, cost and reimbursement.
    Rabinovich M; Fainaru M
    Isr Med Assoc J; 2003 Nov; 5(11):817-8. PubMed ID: 14650110
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term control of recalcitrant psoriasis with combination infliximab and methotrexate.
    Warren RB; Brown BC; Carmichael AJ; Griffiths CE
    Clin Exp Dermatol; 2009 Apr; 34(3):415-6. PubMed ID: 19120390
    [No Abstract]   [Full Text] [Related]  

  • 35. [What are the objectives of moderate to severe psoriasis treatment?].
    Ortonne JP
    Ann Dermatol Venereol; 2008 Jul; 135 Suppl 5():S281-4. PubMed ID: 18721665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infliximab combined with methotrexate as long-term treatment for erythrodermic psoriasis.
    Heikkilä H; Ranki A; Cajanus S; Karvonen SL
    Arch Dermatol; 2005 Dec; 141(12):1607-10. PubMed ID: 16365275
    [No Abstract]   [Full Text] [Related]  

  • 37. Recommendations for the long-term treatment of psoriasis with infliximab: a dermatology expert group consensus.
    Reich K; Griffiths C; Barker J; Chimenti S; Daudén E; Giannetti A; Gniadecki R; Katsambas A; Langley R; Mrowietz U; Ogilvie A; Ortonne JP; Reider N; Saurat JH
    Dermatology; 2008; 217(3):268-75. PubMed ID: 18685261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term management of generalized pustular psoriasis with infliximab: case series.
    Routhouska SB; Sheth PB; Korman NJ
    J Cutan Med Surg; 2008; 12(4):184-8. PubMed ID: 18627699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infliximab, as sole or combined therapy, induces rapid clearing of erythrodermic psoriasis.
    Takahashi MD; Castro LG; Romiti R
    Br J Dermatol; 2007 Oct; 157(4):828-31. PubMed ID: 17711530
    [No Abstract]   [Full Text] [Related]  

  • 40. Autoimmune hepatitis in two psoriasis patients treated with inflixmab.
    Goujon C; Dahel K; Bérard F; Guillot I; Gunera-Saad N; Nicolas JF
    J Am Acad Dermatol; 2010 Aug; 63(2):e43-4. PubMed ID: 20633783
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.